Targeting HER2-positive breast cancer: advances and future directions
Sandra M. SwainDepartment of Medicine, Georgetown Lombardi Comprehensive Cancer Center and MedStar Health, Washington, DC, USA. [email protected]Mythili ShastrySarah Cannon Research Institute, Nashville, TN, USAErika HamiltonSarah Cannon Research Institute, Nashville, TN, USA
2022en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
3 ta iqtibos0 ta foydalanilgan manba